Michael Blum
Net worth: 9 388 $ as of 2024-06-29
Career history of Michael Blum
Former positions of Michael Blum
| Companies | Position | Start | End |
|---|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Corporate Officer/Principal | 2015-03-31 | 2017-10-31 |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 2013-09-30 | 2015-03-31 |
| Q32 BIO INC. | Corporate Officer/Principal | 2017-10-31 | - |
Training of Michael Blum
| College of the Holy Cross (Massachusetts) | Undergraduate Degree |
| Babson College | Masters Business Admin |
Statistics
International
| United States | 6 |
Operational
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA. | Health Technology |
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Michael Blum
- Experience
